Skip to product information
1 of 1

ALPL Recombinant Rabbit mAb

ALPL Recombinant Rabbit mAb

Catalog Number: S0B60286 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen ALPL
Synonyms Alkaline phosphatase, tissue-nonspecific isozyme; AP-TNAP; TNS-ALP; TNSALP; Alkaline phosphatase liver/bone/kidney isozyme; Phosphoamidase; Phosphocreatine phosphatase
Location Mitochondrion, Cell membrane
Accession P05186
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Positive Sample HeLa
Purification Protein A
Concentration 1 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:5000-1:20000 Hu

Background

ALPL is a glycosylated homodimeric membrane protein anchored to the cell membrane via glycosylphosphatidylinositol (GPI), and can also localize to the mitochondrial intermembrane space. The core function of this enzyme is to hydrolyze a variety of substrates including pyrophosphate (PPi), pyridoxal-5'-phosphate (PLP), and phosphocreatine, playing a critical role in bone and tooth mineralization—by degrading PPi, which acts as a mineralization inhibitor, it provides the necessary phosphate for hydroxyapatite crystal formation, and its dephosphorylation of osteopontin also facilitates this process. In addition, TNSALP is involved in cerebral vitamin B6 transport, the generation of P2 receptor ligands, and the regulation of adaptive thermogenesis in brown adipose tissue via creatine-mediated futile cycling. Pathogenic mutations in this gene cause hypophosphatasia, a hereditary disorder characterized by defective mineralization of bones and teeth, with clinical manifestations ranging from severe skeletal deformities and hypercalcemia in infancy to recurrent fractures and premature tooth loss in adulthood, depending on the residual enzyme activity levels.

Picture

Western Blot

WB result of ALPL Recombinant Rabbit mAb
Primary antibody: ALPL Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 57 kDa
Observed MW: 80 kDa